Hereditary type 1 neuropathy

Common Name(s)

Hereditary type 1 neuropathy

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hereditary type 1 neuropathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hereditary type 1 neuropathy" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hereditary type 1 neuropathy" returned 12 free, full-text research articles on human participants. First 3 results:

Natural history and biomarkers in hereditary sensory neuropathy type 1.
 

Author(s): Vera Fridman, Anne Louise Oaklander, William S David, Elise A Johnson, Jessica Pan, Peter Novak, Robert H Brown, Florian S Eichler

Journal: Muscle Nerve. 2015 Apr;51(4):489-95.

 

Hereditary sensory and autonomic neuropathy type 1 (HSAN1) is most commonly caused by missense mutations in SPTLC1. In this study we mapped symptom progression and compared the utility of outcomes.

Last Updated: 20 Mar 2015

Go To URL
A novel missense mutation confirms ATL3 as a gene for hereditary sensory neuropathy type 1.
 

Author(s): Dirk Fischer, Maria Schabhüttl, Thomas Wieland, Reinhard Windhager, Tim M Strom, Michaela Auer-Grumbach

Journal: Brain. 2014 Jul;137(Pt 7):e286.

 

Last Updated: 21 Jun 2014

Go To URL
Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2.
 

Author(s): Sinéad M Murphy, Daniela Ernst, Yu Wei, Matilde Laurà, Yo-Tsen Liu, James Polke, Julian Blake, John Winer, Henry Houlden, Thorsten Hornemann, Mary M Reilly

Journal: Neurology. 2013 Jun;80(23):2106-11.

 

To describe the clinical and neurophysiologic phenotype of a family with hereditary sensory and autonomic neuropathy type 1 (HSANI) due to a novel mutation in SPTLC2 and to characterize the biochemical properties of this mutation.

Last Updated: 4 Jun 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hereditary type 1 neuropathy" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
 

Status: Recruiting

Condition Summary: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy; Hereditary Axonal Neuropathy; Hereditary Demyelinated Neuropathy; Polyneuropathy, Inflammatory Demyelinating, Chronic

 

Last Updated: 11 Jul 2016

Go to URL
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
 

Status: Not yet recruiting

Condition Summary: Charcot-Marie-Tooth Disease Type 1A

 

Last Updated: 3 Nov 2015

Go to URL
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
 

Status: Recruiting

Condition Summary: Charcot-Marie-Tooth Disease Type 1A

 

Last Updated: 18 Nov 2016

Go to URL